Voyager Therapeutics (VYGR) Reports Publication of 2nd-Generation Gene Therapy Capsid Demonstrating Further … – StreetInsider.com
|
Voyager Therapeutics (VYGR) Reports Publication of 2nd-Generation Gene Therapy Capsid Demonstrating Further …
StreetInsider.com “Key translational studies in non-human primates are underway by Voyager to evaluate these AAV variant capsids that have the potential to transform our ability to deliver gene therapies to the CNS. We are pleased to be partnered with the Gradinaru … |
